MD · Pediatrix Medical Group, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EPS non-GAAP | $1.07 | Six Months Ended June 30, 2026 | — |
|
|
|||
| Cash from continuing operations | $126.3M | Three Months Ended June 30, 2026 | — |
| Hospital-based patient services same-unit volume | -2.2% | Six Months Ended June 30, 2026 | — |
| Neonatal intensive care unit (NICU) days same-unit volume | -2% | Six Months Ended June 30, 2026 | — |
| Office-based patient services same-unit volume | -2.4% | Six Months Ended June 30, 2026 | — |
| Same-unit revenue attributable to patient volume | 2.1% | Three Months Ended June 30, 2026 | — |
| Same-unit revenue from net reimbursement-related factors | 4% | Three Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted EBITDA non-GAAP | 280M | Year Ended December 31, 2026 | — |
|
|
|||
| Cash from operating activities from continuing operations | $114.6M | Three Months Ended December 31, 2025 | — |
| Hospital-based patient services same-unit volume change | -3.3% | Three Months Ended December 31, 2025 | — |
| Office-based patient services same-unit volume change | -2.3% | Three Months Ended December 31, 2025 | — |
| Same-unit revenue attributable to patient service volumes | -2.7% | Three Months Ended December 31, 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MD
this stock
Pediatrix Medical Group, Inc.
|
$2.13B | +22.6% | -4.9% | 12.6 | 5.1% |
|
HCA
HCA Healthcare, Inc.
|
$90.30B | -12.8% | +7.1% | 14.0 | 2.7% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$30.84B | -4.5% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.76B | +35.1% | +0.9% | 10.4 | 4.0% |
|
FMS
Fresenius Medical Care AG
|
$12.69B | +0.1% | +5.9% | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MD | -1.1% | +1.5% | +32.0% | -1.1% | +22.6% |
| SPY | -0.4% | +2.9% | +11.6% | +3.0% | +12.8% |
| vs SPY | -0.6% | -1.4% | +20.5% | -4.0% | +9.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.